This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brotz, H.
Right arrow Articles by Sahl, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brotz, H.
Right arrow Articles by Sahl, H. G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 03 1995, 714-719, Vol 39, No. 3
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?

H Brotz, G Bierbaum, A Markus, E Molitor and HG Sahl
Institut fur Medizinische Mikrobiologie und Immunologie, Universitat Bonn, Germany.

Mersacidin is an antibiotic peptide produced by Bacillus sp. strain HIL Y-85,54728 that belongs to the group of lantibiotics. Its activity in vivo against methicillin-resistant Staphylococcus aureus strains compares with that of the glycopeptide antibiotic vancomycin (S. Chatterjee, D. K. Chatterjee, R. H. Jani, J. Blumbach, B. N. Ganguli, N. Klesel, M. Limbert, and G. Seibert, J. Antibiot. 45:839-845, 1992). Incubation of Staphylococcus simulans 22 with mersacidin resulted in the cessation of growth and slow lysis. Biosyntheses of DNA, RNA, and protein were not affected, whereas incorporation of glucose and D- alanine was inhibited and a regular reduction in the level of cell wall thickness was observed. Thus, unlike type A lantibiotics, mersacidin does not form pores in the cytoplasmic membrane but rather inhibits cell wall biosynthesis. Comparison with tunicamycin-treated cells indicated that peptidoglycan rather than teichoic acid metabolism is primarily affected. Mersacidin caused the excretion of a putative cell wall precursor into the culture supernatant. The formation of polymeric peptidoglycan was effectively inhibited in an in vitro assay, probably on the level of transglycosylation. In contrast to vancomycin, the activity of mersacidin was not antagonized by the tripeptide diacetyl-L- Lys-D-Ala-D-Ala, indicating that on the molecular level its mode of action differs from those of glycopeptide antibiotics. These data together with electron microscopy suggest that mersacidin acts on a novel target, which opens new perspectives for the treatment of methicillin-resistant S. aureus.


This article has been cited by other articles:

  • Asaduzzaman, S. M., Nagao, J.-i., Iida, H., Zendo, T., Nakayama, J., Sonomoto, K. (2009). Nukacin ISK-1, a Bacteriostatic Lantibiotic. Antimicrob. Agents Chemother. 53: 3595-3598 [Abstract] [Full Text]  
  • Parisot, J., Carey, S., Breukink, E., Chan, W. C., Narbad, A., Bonev, B. (2008). Molecular Mechanism of Target Recognition by Subtilin, a Class I Lanthionine Antibiotic. Antimicrob. Agents Chemother. 52: 612-618 [Abstract] [Full Text]  
  • Holtsmark, I., Mantzilas, D., Eijsink, V. G. H., Brurberg, M. B. (2006). Purification, Characterization, and Gene Sequence of Michiganin A, an Actagardine-Like Lantibiotic Produced by the Tomato Pathogen Clavibacter michiganensis subsp. michiganensis. Appl. Environ. Microbiol. 72: 5814-5821 [Abstract] [Full Text]  
  • Shen, K., Gladitz, J., Antalis, P., Dice, B., Janto, B., Keefe, R., Hayes, J., Ahmed, A., Dopico, R., Ehrlich, N., Jocz, J., Kropp, L., Yu, S., Nistico, L., Greenberg, D. P., Barbadora, K., Preston, R. A., Post, J. C., Ehrlich, G. D., Hu, F. Z. (2006). Characterization, Distribution, and Expression of Novel Genes among Eight Clinical Isolates of Streptococcus pneumoniae. Infect. Immun. 74: 321-330 [Abstract] [Full Text]  
  • Morgan, S. M., O'Connor, P. M., Cotter, P. D., Ross, R. P., Hill, C. (2005). Sequential Actions of the Two Component Peptides of the Lantibiotic Lacticin 3147 Explain Its Antimicrobial Activity at Nanomolar Concentrations. Antimicrob. Agents Chemother. 49: 2606-2611 [Abstract] [Full Text]  
  • Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S. O., Ljungh, A. (2004). Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother 54: 648-653 [Abstract] [Full Text]  
  • Brotz, H., Sahl, H.-G. (2000). New insights into the mechanism of action of lantibiotics--diverse biological effects by binding to the same molecular target. J Antimicrob Chemother 46: 1-6 [Full Text]  
  • Heidrich, C., Pag, U., Josten, M., Metzger, J., Jack, R. W., Bierbaum, G., Jung, G., Sahl, H.-G. (1998). Isolation, Characterization, and Heterologous Expression of the Novel Lantibiotic Epicidin 280 and Analysis of Its Biosynthetic Gene Cluster. Appl. Environ. Microbiol. 64: 3140-3146 [Abstract] [Full Text]  
  • Brotz, H., Bierbaum, G., Leopold, K., Reynolds, P. E., Sahl, H.-G. (1998). The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II. Antimicrob. Agents Chemother. 42: 154-160 [Abstract] [Full Text]  
  • Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., Sahl, H.-G. (2001). Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity. J. Biol. Chem. 276: 1772-1779 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»